Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > ViaCyte

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon Sep 08, 2022 12:34pm

162 Views

Post# 34949717

RE:ViaCyte

Viacyte has another device with stem cells using Crispers technology that makes the cells avoid the immune system and implanted in a patient !

Philip can't even get 7 th patient . Ind by 2024 ... race will be finished and this will be 50 cents again . No urgency ...

Ray Matthews fluff news releases and rigged investor conferences not going to cut it .

Back to $1

<< Previous

Bullboard Posts

Next >>

Canada Goose appoints first creative director